Knowledge & Resources
Global Innovative Contracting analysis, opinion and insights from our experts and global payer network
Indication-Based Pricing: The Simplest Explanation You’ll Ever Read
We examine the complexities of pricing pharmaceuticals with multiple uses or "indications". In contrast with uniform pricing, 'indication-based pricing' (IBP) aligns price with value for each use. We explore successful IBP strategies, challenges like legislative barriers and complex data collection, and discover how IBP benefits both healthcare systems and patients.
Announcements from South Korea (SK) to Denmark (DK) pave the way for further outcomes-based contracting for high-cost oncology drugs
Multi-indication and combination therapies are rapidly influencing the oncology marketplace. Faced with increasing treatment complexity and budget demands, payers across the globe are starting to evolve their approach to contracting.